Blossom Capital

Blossom Capital is a high-conviction venture capital firm based in London that focuses on leading Series A investment rounds for visionary technology founders across Europe and the United States. Founded in 2017 by Ophelia Brown, the firm employs a data-driven approach to identify companies with the potential to build global platforms in sectors such as consumer internet, SaaS, and increasingly, healthcare and life sciences. Blossom's health-related portfolio includes pioneering companies like LabGenius, which utilizes machine learning for antibody discovery, and Inne, a platform for hormone tracking and fertility monitoring. The firm is distinguished by its selective investment strategy, typically partnering with only five to six companies annually to provide intensive operational and strategic support aimed at rapid international scaling.